Mark Cuban Cost Plus Drug Company (MCCPDC) is partnering with multinational pharmaceutical company Lupin Limited and the COPD Foundation to expand access to Tiotropium Bromide Inhalation Powder for chronic obstructive pulmonary disease patients in the U.S.
COPD is a chronic inflammatory lung disease that obstructs airflow from the lungs and causes breathing problems. Tiotropium Bromide treats...
NowPow, a community referral network seeking to address social determinants of health, has partnered with the Chicago Department of Public Health (CDPH) to strengthen its local digital infrastructure and extend the department's contact tracing reach.
In addition to using NowPow's platform to understand which resources a quarantined individual may need and connecting them to supportive services,...
Dublin, Ohio-based Monitored Therapeutics, Inc. (MTI) has received FDA 510(k) clearance for its connected spirometer, GoSpiro. The device, which calculates diagnostic-quality air capacity measurement, was designed specifically for use in a non-clinical setting. As calculations are performed inside the device, GoSpiro can work with any smartphone, tablet or computer without the need for separate...
Patients and their caregivers are playing increasingly prominent roles in research and healthcare technology innovation. As with any emerging shift in healthcare, creating the right foundation to facilitate more robust, inclusive and insightful research comes with challenges, which is where the National Patient Powered Research Network (PPRN) comes in.
“Recruitment into registries and clinical...
In the past week, two new ResearchKit studies have launched. One of the studies, developed at Japan-based Keio University School of Medicine, aims to use health data for the early detection of arrhythmia and cerebral infarction. The other study, conducted by the COPD Foundation, aims to collect data from people with COPD.
Atrial fibrillation can increase the risk of cerebral infarction by...
